Which peptides have no FDA approval and no FDA compounding review?

Short answer

16 substances profiled here have neither an FDA approval nor an FDA compounding review in the sources their profiles cite: 5-Amino-1MQ, Aviptadil, Cerebrolysin, Cibinetide, Cotadutide, Efinopegdutide, Follistatin-344, FOXO4-DRI, Hexarelin, Humanin, IGF-1 LR3, Larazotide, SLU-PP-332, Tesofensine, Thymopentin and Thymosin beta-4.

Each entry below quotes its profile and links to the full answer there.

PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.

Citations

Sources

Coverage and sources →

Numbered markers in the text point here. Each link opens the original public record.

  1. 1
    5-Amino-1-methylquinolinium substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  2. 2
    Certain bulk drug substances for use in compounding that may present significant safety risks ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026

  3. 3
    Aviptadil substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 15, 2026

  4. 4
    Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial (2023) · PMID 37348524 ↗

    The Lancet Respiratory Medicine · Official source · Source checked November 15, 2026

  5. 5
    Cerebrolysin substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  6. 6
    Cibinetide (ARA 290) substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 15, 2026

  7. 7
    Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain (2017) · PMID 28475703 ↗

    Investigative Ophthalmology & Visual Science · Official source · Source checked November 15, 2026

  8. 8
    Cotadutide substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 15, 2026

  9. 9
    Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study (2021) · PMID 34016612 ↗

    Diabetes Care · Official source · Source checked November 15, 2026

  10. 10
    Efinopegdutide substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  11. 11
    Follistatin (activin-binding protein) substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  12. 12
    Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging (2017) · PMID 28340339 ↗

    Cell · Official source · Source checked November 16, 2026

  13. 13
    Examorelin (hexarelin) substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 15, 2026

  14. 14
    Humanin substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  15. 15
    Long-(Arg3) insulin-like growth factor-I (IGF-1 LR3) substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  16. 16
    Larazotide substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 15, 2026

  17. 17
    Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial (2015) · PMID 25683116 ↗

    Gastroenterology · Official source · Source checked November 15, 2026

  18. 18
    SLU-PP-332 (4-hydroxybenzoic acid 2-(2-naphthalenylmethylene)hydrazide) substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  19. 19
    Tesofensine substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  20. 20
    Thymopentin substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  21. 21
    Thymosin beta-4 substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 15, 2026